UK accelerates COVID booster plans in response to OmicronThe UK looks set to extend its COVID-19 booster vaccination programme to all over-18s, as the number of Share XUK accelerates COVID booster plans in response to Omicronhttps://pharmaphorum.com/news/uk-accelerates-covid-booster-plans-in-response-to-omicron/
Enabling the leaders of the futureJanssen’s Mark Larsen, VP & Head of HR at Janssen EMEA, looks at what COVID-19 has taught us Share XEnabling the leaders of the futurehttps://pharmaphorum.com/sales-marketing/enabling-leaders-future/
Pharma pledges rapid response to Omicron COVID variantWith governments around the world announcing measures to curb the new B.1.1.529 variant of COVID-19 – now christened Share XPharma pledges rapid response to Omicron COVID varianthttps://pharmaphorum.com/news/pharma-pledges-rapid-response-to-omicron-covid-variant/
Fall in efficacy of Merck’s molnupiravir puts Pfizer in driver’s seatMerck & Co has reported new data with its oral antiviral molnupiravir that suggests it is not as Share XFall in efficacy of Merck’s molnupiravir puts Pfizer in driver’s seathttps://pharmaphorum.com/news/fall-in-efficacy-of-mercks-molnupiravir-puts-pfizer-in-drivers-seat/
Turkey’s home-grown COVID vaccine project nears fruitionTurkey could have its own COVID-19 vaccine Turkovac available for use by the end of the year, according Share XTurkey’s home-grown COVID vaccine project nears fruitionhttps://pharmaphorum.com/news/turkeys-home-grown-covid-vaccine-project-nears-fruition/
EU authorises first COVID-19 vaccine for 5 to 11 year oldsThe European Medicines Agency (EMA) has approved Pfizer and BioNTech’s COVID-19 vaccine Comirnaty for children between the ages Share XEU authorises first COVID-19 vaccine for 5 to 11 year oldshttps://pharmaphorum.com/news/eu-approves-first-covid-19-vaccine-for-5-to-11-year-olds/
New COVID variant ‘may sidestep vaccine protection’A new variant of COVID-19 identified in Botswana with dozens of mutations is being watched closely, amid fears Share XNew COVID variant ‘may sidestep vaccine protection’https://pharmaphorum.com/news/new-covid-variant-may-sidestep-vaccine-protection/
Innovation and collaboration – the MHRA’s pandemic approachThe pandemic has propelled issues for the pharmaceutical industry to the top of the political and public agenda, Share XInnovation and collaboration – the MHRA’s pandemic approachhttps://pharmaphorum.com/market-access-2/mhra-pandemic-approach-innovation-collaboration/
UK-wide whole genome sequencing for newborns is feasible – but there are some key questions to answer firstGenomics England, the Department of Health and Social Care’s genome-sequencing hub, has this year announced that support for Share XUK-wide whole genome sequencing for newborns is feasible – but there are some key questions to answer firsthttps://pharmaphorum.com/patients/public-approval-whole-genome-sequencing-newborn-screenings-uk-wide-rollout/
